Catatonia, Neuroleptic Malignant Syndrome, and Serotonin Syndrome

Massachusetts General Hospital Handbook of General Hospital Psychiatry

Volumn , Issue , 2004, Pages 513-530

  Fricchione, Gregory L ^a,b   Huffman, Jeff C ^a,b   Stern, Theodore A ^a,b   Bush, George ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547742331     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02767-0.50034-6     Document Type: Chapter

References (93)

1. Taylor MA Catatonia: a review of a behavioral neurologic syndrome. Neuropsychiatry Neuropsychol Behav Neurol 1990, 3:48-72.
2. Fink M, Bush G, Francis A Catatonia: a treatable disorder, occasionally recognized. Direct Psychiatry 1993, 13:1-7.
3. Fricchione G, Bush G, Fozdar M, et al. Recognition and treatment of the catatonic syndrome. J Intensive Care Med 1997, 12:135-147.
4. Kahlbaum K Catatonia 1973, Johns Hopkins University Press, Baltimore. Y. Levy, T. Priden (Eds.).
5. Kraepelin E Dementia praecox and paraphrenia 1971, RE Krieger Publishing, Huntington, NY. facsimile edition. R.M. Barclay, C.M. Robertson (Eds.).
6. Bleuler E Dementia praecox and the group of schizophrenia 1950, International University Press, New York. J.J. Zinkin (Ed.).
7. Fink M, Taylor MA Catatonia: a separate category in DSM IV?. Integrative Psychiatry 1991, 7:2-5.
8. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Washington, DC. ed 4.
9. Philbrick KL, Rummans TA Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994, 6:1-13.
10. Lohr JB, Wisniewski AA Catatonia. The Neuropsychiatric basis of movement disorders 1987, 201-217. Guilford Press, Baltimore. J.B. Lohr, A.A. Wisniewski (Eds.).
11. Mann SC, Caroff SN, Bleir HR, et al. Lethal catatonia. Am J Psychiatry 1986, 143:1374-1381.
12. Dabholkar PD Use of ECT in hysterical catatonia: a case report and discussion. Br J Psychiatry 1988, 153:246-247.
13. Gelenberg AJ The catatonic syndrome. Lancet 1976, 1:1339-1341.
14. Hermesh H, Hoffnung RA, Aizenberg D, et al. Catatonic signs in severe obsessive compulsive disorder. J Clin Psychiatry 1989, 50:303-305.
15. Rosebush PI, Hildebrand AM, Furlong BG, et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990, 51:357-362.
16. Barnes MP, Saunders M, Walls TJ, et al. The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry 1986, 49:991-996.
17. Altshuler LL, Cummings JL, Miles MJ Mutism: review, differential diagnosis and report of 22 cases. Am J Psychiatry 1986, 143:1409-1414.
18. Clothier JL, Pazzaglia P, Freeman TW Valuation and treatment of catatonia (letter). Am J Psychiatry 1989, 146:553-554.
19. Goeke JE, Hagan DS, Goelzer SL, et al. Lethal catatonia complicated by the development of neuroleptic malignant syndrome in a middle-aged female. Crit Care Med 1991, 19:1445-1448.
20. Tandon R, Walden M, Falcon S Catatonia as a manifestation of paraneoplastic encephalopathy. J Clin Psychiatry 1998, 49:121-122.
21. Synder S, Prenzlauer S, Maruyama N, et al. Catatonia in patient with AIDS-related dementia (letter). J Clin Psychiatry 1992, 53:414.
22. Orlando RM, Daghestahi AN A case of catatonia induced by bacterial meningoencephalitis. J Clin Psychiatry 1987, 48:489-490.
23. Wheeler AH, Ziegler MG, Insel PA, et al. Episodic catatonia, hypertension, and tachycardia: elevated plasma catecholamines. Neurology 1985, 35:1053-1055.
24. Korkina MV, Tsivl'ko MA, Kareva MA, et al. Features of catatono-oneiroid paroxysms of schizophrenia manifesting in the puerperal period. ZH Nevropatol Psikhiatr 1983, 83:1702-1707.
25. Miller DD, Sharafuddin MJA, Kathol RG A case of clozapine-induced neuroleptic malignant syndrome. J Clin Psychiatry 1991, 52:99-101.
26. Najara JE, Enikeer IE Risperidone and neuroleptic malignant syndrome: a case report. J Clin Psychiatry 1995, 56:534-535.
27. Kellam AMP The (frequently) neuroleptic (potentially) malignant syndrome. Br J Psychiatry 1990, 157:169-173.
28. Kellam AMP The neuroleptic malignant syndrome, so-called: a survey of the world literature. Br J Psychiatry 1987, 150:752-759.
29. Behan WMH, Bekheit AMO, More IAR The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide. J Neurol Neurosurg Psychiatry 1991, 54:741-743.
30. Wetli CV, Fishbain DA Cocaine-induced psychosis and sudden death in recreational cocaine users. J Foren Sci 1985, 30:873-880.
31. Kosten TR, Kleber HD Sudden death in cocaine abusers: relation to neuroleptic malignant syndrome (letter). Lancet 1987, 1:1198-1199.
32. Carroll BT, Anfinson TJ, Kennedy JC, et al. Catatonic disorder due to general medical conditions. J Neuropsychiatry Clin Neurosci 1994, 6:122-133.
33. Plum F, Posner J Diagnosis of stupor and coma. Contemporary neurology series 1980, 308-311. FA Davis, Philadelphia, PA. ed 3.
34. Bush G, Fink M, Petrides G, et al. Catatonia I. Rating scale and standardized examination. Acta Psychiatr Stand 1996, 93:129-136.
35. Kraepelin E Psychiatrie 1913, vol. 3:806. Johann Ambrosius Barth, Leipzig, Germany. ed 8.
36. Gjessing R Contributions to the understanding of the pathophysiology of catatonic stupors. Arch Gen Psychiatry 1932, 96:379-392.
37. Stauder KH Die toldliche katatinie. Arch Psychiatry Nervenkr 1934, 102:614-634.
38. Mann SC, Caroff SN, Bleier HR, et al. Lethal catatonia. Am J Psychiatry 1986, 143:1374-1381.
39. Caroff S The neuroleptic malignant syndrome. J Clin Psychiatry 1980, 41:79-83.
40. Philbrick KL, Rummans TA Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994, 6:1-13.
41. Kalinowsky LB Lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry 1987, 144:1106-1107.
42. Fricchione GL Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol Psychiatry 1985, 20:304-313.
43. Goforth HW, Carroll BT The overlap of neuroleptic malignant syndrome (NMS) and catatonic diagnoses. J Neuropsychiatry Clin Neurosci 1995, 7:402.
44. Fink M Neuroleptic malignant syndrome and catatonia: one entity or two?. Biol Psychiatry 1996, 39:1-4.
45. Rosebush PI, Mazurek MF Serum iron and neuroleptic malignant syndrome. Lancet 1991, 338:149-151.
46. Carroll BT, Goforth HW Serum iron in catatonia. Biol Psychiatry 1995, 38:776-777.
47. Lee JW Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 1998, 44:499-507.
48. White DA, Robins AH Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991, 158:419-421.
49. White DA Catatonia and the neuroleptic malignant syndrome: a single entity?. Br J Psychiatry 1992, 161:558-560.
50. Mann SC, Caroff SN Lethal catatonia and the neuroleptic malignant syndrome. Psychiatry: a world perspective 1990, vol. 3:287-292. Elsevier Science, Amsterdam. C.N. Stefanis, C.R. Soldatos, A.D. Rambazilas (Eds.).
51. McCall WV, Shelp FE, McDonal WM Controlled investigation of the amobarbital interview for catatonic mutism. Am J Psychiatry 1992, 149:202-206.
52. Henry JA, Woodruff GHA A diagnostic sign in states of apparent unconsciousness. Lancet 1978, 2:920-921.
53. Guze SB The occurrence of psychiatric illness in systemic lupus erythematosus. Am J Psychiatry 1967, 123:1562-1570.
54. Altshuler LL, Cummings JL, Miles MJ Mutism: review, differential diagnosis and report of 22 cases. Am J Psychiatry 1986, 143:1409-1414.
55. Fink M Catatonia. Contemporary behavioral neurology 1997, 289-308. Butterworth/Heinemann, Oxford. M. Trimble, J. Cummings (Eds.).
56. Dysken MW, Kooser JA, Haraszti JS, Davis JM Clinical usefulness of sodium amobarbital interviewing. Arch Gen Psychiatry 1979, 36:789-794.
57. Lew TY, Tollefson G Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biol Psychiatry 1983, 18:1441-1446.
58. Fricchione GL, Cassem NH, Hooberman D, Hobson D Intravenous lorazepam in neuroleptic induced catatonia. J Clin Psychopharmacol 1983, 3:338-342.
59. McEvoy JP, Lohr JB Diazepam for catatonia. Am J Psychiatry 1984, 141:284-285.
60. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990, 51:357-362.
61. Bush G, Fink M, Petrides G, et al. Catatonia: II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996, 93:137-143.
62. Francis A, Chandragiri S, Rizvi S: Lorazepam therapy of the neuroleptic malignant syndrome. Presented at the Annual Meeting of the American Psychiatric Association; May 30-June 4, 1998; Toronto, Ontario, Canada.
63. Mann SC, Caroff SN, Bleier HR, et al. Electroconvulsive therapy of the lethal catatonia syndrome. Convulsive Therapy 1990, 6:239-247.
64. Caroff SN, Mann SC Neuroleptic malignant syndrome. Med Clin North Am 1993, 77:185-202.
65. Sakkas P, Davis JM, Hua J, et al. Pharmacotherapy of neuroleptic malignant syndrome. Psychiat Ann 1991, 21:157-164.
66. Rosebush PI, Stewart T, Mazurek MF The treatment of neuroleptic malignant syndrome: are dantrolene and bromocriptine useful adjuncts to supportive care?. Br J Psychiatry 1991, 159:709-712.
67. Sczesni B, Bittkau S, von Baumgarten F, et al. Intravenous lisuride in the treatment of the neuroleptic malignant syndrome. J Clin Psychopharmacol 1991, 11:185-188.
68. Mahmood T Bromocriptine in catatonic stupor. Br J Psychiatry 1991, 158:437-438.
69. Rogers D Catatonia: a contemporary approach. J Neuropsychiatry Clni Neurosci 1991, 3:334-340.
70. Neppe VM Management of catatonic stupor with L-dopa. Clin Neuropharmacol 1988, 11:90-91.
71. Jones DL, Mogenson GJ Nucleus accumbens to the globus pallidas GABA projection subserving ambulatory activity. Am J Physiol 1980, 238:R63-R69.
72. Sackeim HA, Decina P, Prohovnik I, et al. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry 1983, 18:1301-1310.
73. Kish SJ, Kilnert R, Miriauf M, et al. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. Am J Psychiatry 1990, 147:1358-1363.
74. Nisijima K, Ishiguro T Neuroleptic malignant syndrome: a study of CSF monoamine metabolism. Biol Psychiatry 1990, 27:280-288.
75. Northoff G, Wenke J, Demisch L, et al. Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacology 1995, 122:182-186.
76. Mann SC, Caroff SN, Lazarus A Pathogenesis of neuroleptic malignant syndrome. Psychiat Ann 1991, 23:175-180.
77. Busber M, Schmidt WJ Injection of apomorphine into the medial prefrontal cortex of the rat increases haloperidol-induced catalepsy. Biol Psychiatry 1994, 36:64-67.
78. Reinhard JF, Bannon MJ, Roth RH Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam. Naunyn-Schmiedeberg's Archive Pharmacologia 1982, 318:374-377.
79. Gulati A, Srimal RC, Shawan BN Up-regulation of brain benzodiazepine receptors by electroconvulsive shocks. Pharmacology Research Communications 1986, 18:581-589.
80. Petrides G, Divadeenam KM, Bush G, Francis A Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry 1997, 42:375-381.
81. Alexander GE, Crutcher MD, DeLong MR Basal ganglia-thalamo-cortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990, 85:119-146.
82. Northoff G, Bogerts B, Leseunges A, et al: Alternations in orbitofrontal activity in catatonia: a combined FMRI/MEG study. Presented at the XI World Congress of Psychiatry meeting; August 6-11, 1999; Hamburg, Germany.
83. Friedhoff AJ A strategy for developing novel drugs for the treatment of schizophrenia. Schizophr Bull 1983, 9:555-562.
84. Kim JS, Hassler R Effects of acute haloperidol on the gamma aminobutyric acid system in rat striatum and substantia nigra. Brain Res 1975, 88:150-153.
85. Stevens J, Wilson K, Foote W GABA blockade, dopamine and schizophrenia: experimental studies in the cat. Psychopharmacologia (Berl) 1974, 39:105-119.
86. Kalivas PW, Duffy P, Eberhardt H Modulation of A10 dopamine neurons by gamma-a aminobutyric acid agonists. J Pharmacol Exp Ther 1990, 253:858-866.
87. Jaskiw GE, Weinberger DR, Crawley JN Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentration in the microdialystate from the caudate nucleus. Biol Psychiatry 1991, 29:703-706.
88. Friedhoff AJ, Carr KD, Uysal S, Schweitzer J Repeated inescapable stress produces a neuroleptic like effect on the conditioned avoidance response. Neuro-psychopharmacology 1995, 13:129-138.
89. Gurrera R: The role of calcium and peripheral catecholamines in the pathophysiology of neuroleptic malignant syndrome. Psychiatric Annals 30:356-362, 2(MX).
90. Carroll BT The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectrums 2000, 5:26-33.
91. Keck PE, Arnold LM The serotonin syndrome. Psychiat Ann 2000, 30:333-343.
92. Reddick B, Stern TA Catatonia, neuroleptic malignant syndrome, and serotonin syndrome. Psychiatry, update and board preparation 2004, 219-226. McGraw Hill, New York. ed 2. T.A. Stern, J.B. Herman (Eds.).
93. Sternbach H The serotonin syndrome. Am J Psychiatry 1991, 148:705-713.